Shares of DermTech (DMTK) Risen 186% Over A Month

After announcing that its test had earned insurance coverage, the shares of biotech firm DermTech, Inc. (DMTK) started rising last month. The rally is still going on as the stock has added more than 186% over one month. . Now the business can depend on market growth, as with the DermTech Pigmented Lesion Assay (PLA) genomic test, more patients will be able to afford to test.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free

For PLA studies, the American insurance provider Geisinger Health System has approved medical insurance payments. Such studies are the newest early warning technology for melanoma (skin cancer). Its particularity is high precision: at an early stage, the risk of losing cancer is less than 1 percent. This is particularly important for this condition, as timely diagnosis decreases the risk of a dangerous course of the disease. Early disease identification systems are being implemented in certain countries’ health services as the most reliable means of sustaining health and reducing costs.

Naturally, the announcement of the introduction of DermTech technology became the engine of price rise of the stock as it has risen 27% on December 30 session. In the US health insurance market, Geisinger is one of the participants. Geisinger’s case, however, can contribute to a sequence of similar choices by other insurers. The fact that the PLA test was historically approved for reimbursement by Illinois insurance providers Blue Cross Blue Shield and California Blue Shield is in favor of this.

What effect Geisinger’s acceptance would have on the financial results of DermTech is not yet apparent. In February 2021, the organization expects to issue the next update (for the fourth quarter).

At the January 15 trading, DermTech, Inc. (DMTK) was down -1.69% to $39. The capitalization of the market now stands at $945 million


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

$2.04M in average volume shows that Canadian Natural Resources Ltd. (CNQ) is heading in the right direction

Canadian Natural Resources Ltd. (NYSE: CNQ) on September 29, 2023, started off the session at the price of $66.42, plunging -2.21% from the previous...

Recent developments with Sprinklr Inc (CXM) have led to the company’s beta value being reach 0.91 cents.

September 29, 2023, Sprinklr Inc (NYSE: CXM) trading session started at the price of $13.96, that was -3.22% drop from the session before. During...

Ur-Energy Inc. (URG) posted a -1.91% change over the last five days signaling a new trend

On September 29, 2023, Ur-Energy Inc. (AMEX: URG) opened at $1.68, lower -7.23% from the last session. During the day, the shares moved up...


Please enter your comment!
Please enter your name here